Amandala Neuro operates as a clinical-stage biopharmaceutical company developing psychedelic treatments within the mental health sector
Amandala Neuro operates as a clinical-stage biopharmaceutical company developing psychedelic treatments within the mental health sector. Their main offerings include psychedelic treatments aimed at fitting into the psychiatric care model.
The top three firms on F4's Biotech & Life Sciences investor list.